News & Events
6 July 2021
Live-remote training during the Corona pandemic Because training centers were closed in Germany, the Heidelberg University Hospital developed a live-remote exercise intervention for participants of the EFFECT trial. Patients successfully follow the study intervention from their living rooms. They train as hard as in-person and enjoy the interaction with the trainer and the other participants.
READ MORE8 April 2021
100 patients in EFFECT trial and all countries now recruiting The team of Onkologikoa in San Sebastian, Spain, had the honor of including the 100th patient in the EFFECT trial.
In addition, the first few patients have been included in Poland, which means that all countries are now recruiting.
READ MORE23 March 2021
5th PREFERABLE Consortium Meeting We just completed our 5th PREFERABLE consortium meeting. Great to work as a team with very motivated people. It is also encouraging that recruitment is going well under the current circumstances for both the EFFECT and PERSPECTIVE study.
READ MORECollaboration
PREFERABLE consists of an international consortium of nine academic partners, one cutting edge game development and software engineering SME , one science-driven clinical trial management company and one European patient organisation (EUROPA DONNA – The European Breast Cancer Coalition, representing 47 countries throughout Europe). The partners are from seven countries in the Netherlands, Germany, Sweden, Poland, Spain, Italy and Australia and are coordinated by the University Medical Center Utrecht, the Netherlands.
